Nu-Med Plus NUMD
OTC NUMD
$0.01 +0.00 (+0.00%)
At close: Sep 29, 2026 · 4:00 PM EDT

Nu-Med Plus (NUMD) Liabilities and Shareholders Equity (2011 - 2026)

Updated

Nu-Med Plus (NUMD) recorded Liabilities and Shareholders Equity of $12,909 in Q2 2026, up 58.1% from $8,163 a year earlier.

Analysis

Nu-Med Plus (NUMD) Liabilities and Shareholders Equity (2011 - 2026) Analysis & Trends

At the end of FY2025, Nu-Med Plus reported Liabilities and Shareholders Equity of $7,911, down 15.6% from FY2024.

  • Annual Liabilities and Shareholders Equity has declined for three straight years, with a five-year compound annual growth rate of -57.3% (FY2020 to FY2025).
  • Across earlier years, Liabilities and Shareholders Equity came in at $9,373 in FY2024 (-30.3%), $13,456 in FY2023 (-83.1%), $79,545 in FY2022 (+258.9%) and $22,163 in FY2021 (-96.0%).
  • The Q2 2026 figure is the highest quarterly Liabilities and Shareholders Equity since Q4 2023.
  • On a year-over-year basis, Liabilities and Shareholders Equity rose in 1 of the last seven quarters, with an average decline of 19.0%.
  • Peak year-over-year performance for Liabilities and Shareholders Equity in the last five years was growth of 645.3% in Q1 2023, against a decline of 97.2% in Q1 2022 at the low end.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Thermo Fisher Scientific 249.71 Bn 228.86 Bn 4.88 Bn 113.17 Bn
2 Abbott Laboratories 171.00 Bn 142.08 Bn 7.27 Bn 109.22 Bn
3 Danaher 155.79 Bn 139.61 Bn 3.61 Bn 92.37 Bn
4 Intuitive Surgical 143.91 Bn 123.46 Bn 1.96 Bn 20.88 Bn
5 Medtronic 110.42 Bn 76.29 Bn 6.34 Bn 93.31 Bn
6 Stryker 105.71 Bn 91.82 Bn 4.50 Bn 47.93 Bn
7 Boston Scientific 63.26 Bn 58.27 Bn 3.85 Bn 45.22 Bn
8 Edwards Lifesciences 49.80 Bn 33.91 Bn 1.35 Bn 13.87 Bn
9 Becton Dickinson 48.78 Bn 45.93 Bn 2.32 Bn 50.73 Bn
10 Nu-Med Plus 835,484.67 826,603.67 - 12,909.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 12,909.00
Dec 31, 2025 7,911.00
Sep 30, 2025 5,048.00
Jun 30, 2025 8,163.00
Mar 31, 2025 5,173.00
Dec 31, 2024 9,373.00
Sep 30, 2024 6,841.00
Jun 30, 2024 11,041.00
Mar 31, 2024 9,016.00
Dec 31, 2023 13,456.00
Sep 30, 2023 13,748.00
Jun 30, 2023 36,547.00
Mar 31, 2023 59,069.00
Dec 31, 2022 79,545.00
Sep 30, 2022 3,168.00
Jun 30, 2022 8,440.00
Mar 31, 2022 7,926.00
Dec 31, 2021 22,163.00
Sep 30, 2021 51,236.00
Jun 30, 2021 89,130.00
API Access

Nu-Med Plus Liabilities and Shareholders Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=NUMD&period=max&api_key=YOUR_API_KEY